Sirolimus treatment for recurrent lymphangioleiomyomatosis after lung transplantation.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19101258.
- Also identified by DOI 10.1016/j.athoracsur.2008.07.107.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pulmonary lymphangioleiomyomatosis is a rare disease that generally progresses to respiratory failure. We experienced a patient who had recurring lymphangioleiomyomatosis in the transplanted lungs. A chest computed tomographic scan showed a progressing emphysematous change. The patient had a subclinical extent of pan-circumferential stricture at the distal site of the left bronchial anastomosis. We treated the patient with sirolimus for three years. Chest computed tomography showed no sign of exacerbation during the late 3 years, whereas pulmonary function test revealed a slight increase after the use of sirolimus. Bronchial stricture also disappeared almost completely. This is the first reported case with sirolimus treatment for post-transplant recurrent lymphangioleiomyomatosis.
Medical subject headings
- Immunosuppressive Agents
- Lung Neoplasms
- Lung Transplantation
- Lymphangioleiomyomatosis
- Sirolimus